Medicure Inc.
MPH.V
TSX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -6.74% | 3.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.74% | 3.45% | |||
| Cost of Revenue | -24.10% | 7.23% | |||
| Gross Profit | 30.87% | -3.91% | |||
| SG&A Expenses | -47.61% | 70.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -34.89% | 33.56% | |||
| Operating Income | 91.36% | -221.13% | |||
| Income Before Tax | 90.46% | -209.22% | |||
| Income Tax Expenses | -81.48% | -23.19% | |||
| Earnings from Continuing Operations | 90.36% | -198.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 90.36% | -198.71% | |||
| EBIT | 91.36% | -221.13% | |||
| EBITDA | 104.19% | -444.16% | |||
| EPS Basic | 90.35% | -198.76% | |||
| Normalized Basic EPS | 90.54% | -211.55% | |||
| EPS Diluted | 90.07% | -198.76% | |||
| Normalized Diluted EPS | 90.54% | -211.55% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||